Form 4: Bausch Health Executive Aimee Lenar Receives Significant RSU Award

Bausch Health Companies Inc. EVP, US Pharma, Aimee J. Lenar, was granted 30,847 restricted share units (RSUs) on July 17, 2025, as part of her compensation.

Summary

• Aimee J. Lenar, Executive Vice President of US Pharma at Bausch Health Companies Inc. (BHC), acquired 30,847 common shares through an award of restricted share units (RSUs).
• The transaction occurred on July 17, 2025, with a reported price of $0 per share, indicating a grant rather than a purchase.
• Following this transaction, Ms. Lenar's total beneficial ownership of Bausch Health common shares stands at 260,774.
• The awarded RSUs will vest in three equal annual installments, with one-third vesting on each of the first three anniversaries of the grant date, contingent upon Ms. Lenar's continued service.
• Vested RSUs will be settled in common shares of Bausch Health Companies Inc.

Sentiment

Score: 6

Explanation: The sentiment is slightly positive as the RSU grant is a routine compensation event that aligns executive interests with shareholders and aids in retention, without indicating any negative operational or financial issues.

Positives

• The grant of restricted share units to a key executive like Aimee J. Lenar aligns her long-term interests with those of shareholders, as the value of the award is tied to the company's stock performance.
• This RSU award serves as a retention mechanism, incentivizing Ms. Lenar to remain with the company for at least three years to fully vest her shares.

Future Outlook

The awarded restricted share units are scheduled to vest one-third on each of the first three anniversaries following the grant date of July 17, 2025, subject to the reporting person's continued service.

Industry Context

The grant of restricted share units (RSUs) is a standard and widely adopted practice in executive compensation across various industries, including pharmaceuticals and healthcare, to attract, retain, and incentivize key talent by aligning their financial interests with the long-term performance of the company.

Corporate Governance

Stakeholder Impact

• Shareholders: The RSU grant, while potentially leading to minor dilution upon vesting, primarily serves to align the interests of a key executive with shareholder value, potentially fostering long-term growth.
• Employees: This type of executive compensation reinforces the company's commitment to retaining top talent and may serve as a benchmark for broader employee incentive programs.

Next Steps

• Vesting of one-third of the restricted share units on the first, second, and third anniversaries of the July 17, 2025 grant date, contingent on continued service.

Key Dates

Keywords

Bausch Health, BHC, Form 4, Insider Transaction, Restricted Share Units, RSU, Executive Compensation, Aimee J. Lenar, Stock Grant